CRDL
Cardiol Therapeutics·NASDAQ
--
--(--)
--
--(--)
7.46 / 10
Outperform
Analyst consensus is a Strong Buy (100%) with a weighted rating of 7.69, while fund‑flow score is 7.24 (good). Inflow ratios hover around 0.38‑0.48 but trends are negative across all size segments, indicating supportive yet waning buying pressure.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-10
InstitutionHC Wainwright & Co.
Times predicted3
Historical Win Rate33.3%
What is the market sentiment for CRDL?
- CRDL holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.46/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
